Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-10-31

FDA Approved: VOQUEZNA TRIPLE PAK — Supplemental Application (Phathom Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Voquezna Triple Pak, a three-drug regimen of vonoprazan fumarate, amoxicillin, and clarithromycin, for the treat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMOXICILLIN (AMOXICILLIN)
  • clarithromycin (clarithromycin)
  • vonoprazan fumarate (vonoprazan)

Snippet

SUPPL AP for VOQUEZNA TRIPLE PAK (VONOPRAZAN FUMARATE, AMOXICILLIN AND CLARITHROMYCIN)